SEC Form 4 · accession 0000899243-17-001670
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Scott McDowell
Officer — See Remarks
Period of report
Jan 18, 2017
Accepted (ET)
Jan 20, 2017 · 5:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $12.25 | Jan 18, 2017 | A | 79,850 | A | — | Jan 17, 2027 | Common Stock | 79,850 | 79,850 | D |
Explanation of responses
- F1The shares underlying the option vest in 48 equal monthly installments from January 1, 2017, so long as the Reporting Person continues to be an employee of the Issuer through each vesting date. This option is subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Remarks
Senior Vice President, Drug Discovery